Document is current
Any future updates will be listed below
-
Authors
Richardson, Paul G. https://orcid.org/0000-0002-7426-8865
Perrot, Aurore https://orcid.org/0000-0003-0131-8689
Mikhael, Joseph https://orcid.org/0000-0001-9670-2864
Martin, Thomas https://orcid.org/0000-0002-9133-9813
Beksac, Meral https://orcid.org/0000-0003-1797-8657
Spicka, Ivan https://orcid.org/0000-0002-5451-5283
Capra, Marcelo
D’Agostino, Mattia
Sonneveld, Pieter https://orcid.org/0000-0002-0808-2237
Bisht, Kamlesh
Fukao, Taro
Zhang, Rick
Tada, Keisuke https://orcid.org/0000-0003-3051-5841
Tekle, Christina
Macé, Sandrine
Klippel, Zandra
van de Velde, Helgi
Moreau, Philippe https://orcid.org/0000-0003-1780-8746
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 5 June 2024
Revised: 13 September 2024
Accepted: 18 September 2024
First Online: 28 November 2024
Competing interests
: PGR reports research funding from Celgene/BMS, Karyopharm, Oncopeptides, and Takeda; and participation on advisory boards for AstraZeneca, Celgene/BMS, GSK, Karyopharm, Oncopeptides, Regeneron, and Sanofi. AP reports honoraria from AbbVie, Amgen, BMS/Celgene, GSK, Janssen, Pfizer, Sanofi, and Takeda; research funding from Takeda; and support for attending meetings and/or travel from Amgen and Janssen. JM reports consulting fees from Amgen, BMS, Janssen, Karyopharm, Sanofi, and Takeda. TM reports research funding from Sanofi. MB reports honoraria from Janssen, Sanofi, and Takeda; and participation on a data safety monitoring board or advisory board for Amgen, Menarini, Sanofi, and Takeda. IS reports honoraria from Amgen, BMS, GSK, Janssen, Karyopharm, Sanofi, and Takeda; and participation on a data safety monitoring board or advisory board for Amgen, BMS, GSK, Janssen, Karyopharm, Sanofi, and Takeda. MC reports honoraria from BMS, Janssen, and Sanofi; and support for attending meetings and/or travel from Janssen and Sanofi. MD reports honoraria from GSK, Janssen, and Sanofi; and participation on a data safety monitoring board or advisory board for BMS, GSK, and Sanofi. PS reports research funding/honoraria from Amgen, Janssen, Karyopharm, Pfizer, and Sanofi. KB, TF, KT, CT, SM, RZ, ZK, and HvdV are employees of Sanofi and may hold stock and/or stock options. PM reports participation on a data safety monitoring board or advisory board for AbbVie, Amgen, Celgene, Janssen, Sanofi, and Takeda.
